Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors Peer median
Operating Margin for KARD and competitors
Company Period LTM level YoY 3-year change
RNAAtrium Therapeutics, Inc.FY2025-412.6% ——
CYTKCytokinetics, IncorporatedLTM Jun 2026-993.0% -355.0 pp-352.7 pp
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026-3432.2% -3162.2 pp-999.4 pp
TNYATenaya Therapeutics, Inc.LTM Mar 2026-38159.1% ——
KARDKardigan, Inc.—— ——
IKTInhibikase Therapeutics, Inc.FY2025— ——
Peer median (excluding KARD) -2212.6%-1758.6 pp-676.1 pp

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.